Blood Transfusion Services is an essential part of the National Health Service. There is no substitute for Blood and its components. Blood transfusion is lifesaving in some situations as well as it has potential life threatening hazards. Transfusion of unscreened blood and its components significantly exposes the patient to potential risk of transmitting infections like HIV, Hepatitis, Syphilis and Malaria etc. and increases the morbidity and mortality.
Even with strict strategies and policies, transmission of disease still occurs because of inability of testing methods to detect the infection in ‘window …show more content…
Records of total 706853 donors were analysed for the study. The Voluntary donations were primarily obtained from blood donation camps organised by the NGO’s and societies. Replacement donors include family members, friends of the ailing patients and close relatives. Care was taken to avoid paid/professional donors by taking medical history and clinical examination. Basic information of donors including age, sex, occupation, medication, previous donations etc. were obtained. Donors were selected as per inclusion and exclusion criterion as …show more content…
This survey gives the idea about the epidemiology of these diseases in community and also helps in assessing the safety of blood products.
As per Indian National AIDS Control Organization [2011-2012] India has the third largest number of people living with HIV/AIDS. The adult HIV prevalence at national level has showed steady decline from 0.41% in 2000 through 0.36% in 2006 to 0.31% in 2009. Rajasthan shows increase from 0.12% to 0.19%. The states of Bihar, Orrisa, West Bengal, Rajasthan, Uttar Pradesh, Gujrat and Madhya Pradesh together account for 41% of new infections. (National AIDS Control Programme Phase III March 2012).
WHO placed India in the intermediate zone in the prevalence of Hepatitis B (2-7%).Prevalence of HbsAg in our blood donors is 1.83% comparable to the study done by Chandra et al, and Srikrishna et al. On the other hand the prevalence of HBV is lower in Western Europe and United States (0.1-0.5%) and reported to be higher, 5-15% in China and South East Asia